Hypertension Diagnostics, Inc.
HDII
$0.00
$0.000.00%
| 03/31/2013 | 12/31/2012 | 09/30/2012 | 06/30/2012 | 03/31/2012 | |
|---|---|---|---|---|---|
| Revenue | -99.96% | -98.88% | 2,783.33% | -63.77% | 430.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -99.96% | -98.88% | 2,783.33% | -63.77% | 430.10% |
| Cost of Revenue | -88.64% | -78.42% | 235.86% | -- | -- |
| Gross Profit | -185.01% | -30,712.50% | -163.59% | -- | -- |
| SG&A Expenses | -66.80% | -53.97% | 1.88% | 271.62% | 684.09% |
| Depreciation & Amortization | -- | -- | -- | 72.00% | -- |
| Other Operating Expenses | -- | -- | -- | 70.16% | -- |
| Total Operating Expenses | -82.99% | -74.17% | 44.20% | 707.40% | 2,930.98% |
| Operating Income | -6.01% | -43.88% | -30.48% | -556.25% | -385.20% |
| Income Before Tax | -18.69% | -67.75% | -89.11% | -587.18% | -469.92% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -18.69% | -67.75% | -89.11% | -587.18% | -469.92% |
| Earnings from Discontinued Operations | -136.59% | 699.40% | 63.63% | 3.28% | 1,402.87% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11,325.00% | 80.10% | 27.89% | -110.15% | 105.48% |
| EBIT | -6.01% | -43.88% | -30.48% | -556.25% | -385.20% |
| EBITDA | -4.50% | -37.42% | -16.07% | -518.36% | -335.00% |
| EPS Basic | -12,100.00% | 83.67% | 40.60% | -108.16% | 104.17% |
| Normalized Basic EPS | -9.62% | -39.47% | -29.41% | -466.67% | -420.00% |
| EPS Diluted | -396.15% | 63.33% | 34.19% | -108.16% | -8.33% |
| Normalized Diluted EPS | -26.67% | -39.39% | -29.41% | -580.00% | -350.00% |
| Average Basic Shares Outstanding | 8.45% | 20.92% | 20.92% | 21.12% | 11.95% |
| Average Diluted Shares Outstanding | -5.85% | 17.89% | 20.92% | 3.55% | 28.95% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
